TP53 and liver cancer: Notably, a very recent study demonstrated that berberine sensitizes liver cancer cells to sorafenib by inducing SETDB1/NQO1/p53-dependent ferroptosis and genomic instability [32], providing independent validation of berberine’s involvement in p53-related mechanisms.